Search research articles
Contact Us
Filters
Showing results (101-110 of 112) with videos related to
Page
of 12
Sort By:
Antimicrobial Agents and Chemotherapy
|
November 16, 2023
Plasmid genomic epidemiology of <i>bla</i><sub>KPC</sub> carbapenemase-producing <i>Enterobacterales</i> in Canada, 2010-2021
Nicole Lerminiaux, Robyn Mitchell, Jessica Bartoszko, et al.
Gastroenterology
|
October 4, 2024
Safety and Tolerability of CP101, a Full-Spectrum, Oral Microbiome Therapeutic for the Prevention of Recurrent Clostridioides difficile Infection: A Phase 2 Randomized Controlled Trial
Jessica R Allegretti, Colleen R Kelly, Thomas Louie, et al.
Kidney Cancer (Clifton, Va.)
|
October 19, 2018
Outcomes of Metastatic Chromophobe Renal Cell Carcinoma (chrRCC) in the Targeted Therapy Era: Results from the International Metastatic Renal Cell Cancer Database Consortium (IMDC)
Steven M Yip, Jose M Ruiz Morales, Frede Donskov, et al.
Journal of the American Chemical Society
|
November 8, 2023
In Situ Structural Observation of a Substrate- and Peroxide-Bound High-Spin Ferric-Hydroperoxo Intermediate in the P450 Enzyme CYP121
Romie C Nguyen, Ian Davis, Medhanjali Dasgupta, et al.
Antimicrobial Resistance and Infection Control
|
July 12, 2025
The evolving epidemiology of Carbapenemase-producing Enterobacterales in Canadian acute care facilities, 2010-2023
Robyn Mitchell, Laura Mataseje, Joëlle Cayen, et al.
Infection Control and Hospital Epidemiology
|
August 18, 2022
Trends in <i>Clostridioides difficile</i> infection rates in Canadian hospitals during the coronavirus disease 2019 (COVID-19) pandemic
Kelly B Choi, Tim Du, Anada Silva, et al.
Antiviral Research
|
September 14, 2025
CCHFV-M based DNA vaccine is highly immunogenic in multiple species and protects against challenge in cynomolgus macaques
John J Suschak, Collin J Fitzpatrick, Charles J Shoemaker, et al.
Emerging Infectious Diseases
|
April 26, 2022
Characterization of Healthcare-Associated and Community-Associated Clostridioides difficile Infections among Adults, Canada, 2015-2019
Tim Du, Kelly B Choi, Anada Silva, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
June 27, 2018
The evolving epidemiology of <i>Clostridium difficile</i> infection in Canadian hospitals during a postepidemic period (2009-2015)
Kevin C Katz, George R Golding, Kelly Baekyung Choi, et al.
Infection Control and Hospital Epidemiology
|
October 30, 2025
Preparedness for <i>Candida auris</i> in Canadian Nosocomial Infection Surveillance Program (CNISP) hospitals, 2024
Charlie Tan, Amrita Bharat, Erin McGill, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 112) with videos related to
Sort By:
Page
of 12
Antimicrobial Agents and Chemotherapy
|
November 16, 2023
Plasmid genomic epidemiology of <i>bla</i><sub>KPC</sub> carbapenemase-producing <i>Enterobacterales</i> in Canada, 2010-2021
Nicole Lerminiaux, Robyn Mitchell, Jessica Bartoszko, et al.
Gastroenterology
|
October 4, 2024
Safety and Tolerability of CP101, a Full-Spectrum, Oral Microbiome Therapeutic for the Prevention of Recurrent Clostridioides difficile Infection: A Phase 2 Randomized Controlled Trial
Jessica R Allegretti, Colleen R Kelly, Thomas Louie, et al.
Kidney Cancer (Clifton, Va.)
|
October 19, 2018
Outcomes of Metastatic Chromophobe Renal Cell Carcinoma (chrRCC) in the Targeted Therapy Era: Results from the International Metastatic Renal Cell Cancer Database Consortium (IMDC)
Steven M Yip, Jose M Ruiz Morales, Frede Donskov, et al.
Journal of the American Chemical Society
|
November 8, 2023
In Situ Structural Observation of a Substrate- and Peroxide-Bound High-Spin Ferric-Hydroperoxo Intermediate in the P450 Enzyme CYP121
Romie C Nguyen, Ian Davis, Medhanjali Dasgupta, et al.
Antimicrobial Resistance and Infection Control
|
July 12, 2025
The evolving epidemiology of Carbapenemase-producing Enterobacterales in Canadian acute care facilities, 2010-2023
Robyn Mitchell, Laura Mataseje, Joëlle Cayen, et al.
Infection Control and Hospital Epidemiology
|
August 18, 2022
Trends in <i>Clostridioides difficile</i> infection rates in Canadian hospitals during the coronavirus disease 2019 (COVID-19) pandemic
Kelly B Choi, Tim Du, Anada Silva, et al.
Antiviral Research
|
September 14, 2025
CCHFV-M based DNA vaccine is highly immunogenic in multiple species and protects against challenge in cynomolgus macaques
John J Suschak, Collin J Fitzpatrick, Charles J Shoemaker, et al.
Emerging Infectious Diseases
|
April 26, 2022
Characterization of Healthcare-Associated and Community-Associated Clostridioides difficile Infections among Adults, Canada, 2015-2019
Tim Du, Kelly B Choi, Anada Silva, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
June 27, 2018
The evolving epidemiology of <i>Clostridium difficile</i> infection in Canadian hospitals during a postepidemic period (2009-2015)
Kevin C Katz, George R Golding, Kelly Baekyung Choi, et al.
Infection Control and Hospital Epidemiology
|
October 30, 2025
Preparedness for <i>Candida auris</i> in Canadian Nosocomial Infection Surveillance Program (CNISP) hospitals, 2024
Charlie Tan, Amrita Bharat, Erin McGill, et al.
Page
of 12